Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 93

Results For "cost"

1277 News Found

Phablecare acquires Fused Training, a startup combating Type-1 Diabetes
Startup | March 31, 2022

Phablecare acquires Fused Training, a startup combating Type-1 Diabetes

Phablecare closed this acquisition for an undisclosed sum, betting on the start-up's holistic approach to Type 1 Diabetes management


Rotary Club of Delhi South carriers out large-scale relief work across leprosy colonies
Public Health | March 30, 2022

Rotary Club of Delhi South carriers out large-scale relief work across leprosy colonies

India accounts for more than half (almost 60%) of new leprosy cases worldwide, despite being declared ‘leprosy-free’ in 2005.


Sanofi and IGM Biosciences team up to commercialise IgM antibody agonists
Biotech | March 30, 2022

Sanofi and IGM Biosciences team up to commercialise IgM antibody agonists

Companies to leverage proprietary IgM antibody technology platform to discover agonists against three oncology targets and three immunology/inflammation targets


GenScript wins Best CDMO award for the third time
News | March 30, 2022

GenScript wins Best CDMO award for the third time

The award also follows GenScript's recognition at the Korea Bioprocessing Excellence Awards in 2021 for the "Best Contract Development and Manufacturing Organization Award".


TDB approves funding for MIM in MedTech
News | March 30, 2022

TDB approves funding for MIM in MedTech

Technology Development Board supports commercialisation of Metal Injection Molding of implants


Dysval gets regulatory approval in Japan
Drug Approval | March 29, 2022

Dysval gets regulatory approval in Japan

Tardive dyskinesia (TD) is a movement disorder that is characterized by uncontrollable, abnormal and repetitive movements of the face, torso and/or other body parts, which may be disruptive and negatively impact patients


Lawrence Berkeley lab offers trial kit for CRAGE Genome Engineering Tool
Medical Device | March 29, 2022

Lawrence Berkeley lab offers trial kit for CRAGE Genome Engineering Tool

Novel tool bypasses plasmid-based expression to increase stability and significantly reduce development time for a variety of synthetic biotechnology products


AbbVie to showcase neuroscience portfolio at AAN 2022 annual meeting
Biotech | March 29, 2022

AbbVie to showcase neuroscience portfolio at AAN 2022 annual meeting

AbbVie to present 30 abstracts demonstrating its leadership in neuroscience, including continued migraine treatment research across the spectrum of the disease, commitment to patients with advanced Parkinson's disease, and new studies in spasticity and cervical dystonia


Govt signs agreement with Sapigen Biologix to develop two vaccines
News | March 28, 2022

Govt signs agreement with Sapigen Biologix to develop two vaccines

Under the agreement, Technology Development Board and Bharat Biotech have pledged the support of Rs.200 crore each to create a continuous corpus of Rs.400 crores for the project


Aster DM Healthcare signs MoU with Tamil Nadu govt to invest Rs. 500 crore
Hospitals | March 27, 2022

Aster DM Healthcare signs MoU with Tamil Nadu govt to invest Rs. 500 crore

The MoU proposed investments in hospitals, pharmacies and laboratories in the state